VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | Primary refractory young myeloma: a difficult clinical situation

Salomon Manier • 8 May 2020
COMy Virtual 2020
Multiple Myeloma Bortezomib Carfilzomib Dexamethasone Lenalidomide

Salomon Manier, MD, PhD, Lille Hospital University, Lille, France, discusses challenging cases in primary refractory young multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Salomon Manier

3:28
Molecular prognostication in SMM
Salomon Manier • 8 May 2020

Related Videos

3:15
Updates on transplant for patients with myeloma
Sergio A. Giralt • 22 Feb 2021
5:23
Homozygous BCMA deletion in response to ide-cel in myeloma patient
Leo Rasche • 19 Feb 2021
1:45
CAR T-cells in myeloma: patients’ perspective
Ananda Plate • 11 Feb 2021
3:41
The importance of partnering with patient organizations
Ananda Plate • 11 Feb 2021
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals